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INTRODUCTION
Recent epidemiological evidence supports a strong relationship between
Helicobacterpylori infection and gastric cancer [1-11]. The relative risk for cancer with
an infection of five years and over is in the region of three to six (Table 1). The identifi-
cation ofalmost universal co-existence ofH. pylori related antral gastritis in patients with
duodenal ulcer disease [12, 13] and the subsequent proof of significant reduction in duo-
denal ulcerrelapse rate after successful eradication oftheorganism [14-16] forms the plat-
form that H. pylori infection is aetiologically related to duodenal ulceration. Although the
relationship between H. pylori infection and gastric ulcer disease appears less convincing
than that between H. pylori infection and duodenal ulcer disease, there has been recent
evidence from therapeutic study that successful eradication of the organism helps to
reduce the gastric ulcer relapse significantly [17]. It is generally accepted that patients
with duodenal ulcer seldom develop gastric cancer, the chance of an associated gastric
cancer having been estimated to be one-fifth of that of gastric ulcer [18]. It thus appears
that H. pylori infection occupies a common ground for three divergent conditions.
Geographical differences in the prevalence of peptic ulcer within the same country
have been well described, such as the higher frequency in the north than in the south of
India, in Scotland than in England, or in the west than in the east of Australia [19-21].
However, the relationship of the ulcer and cancer distribution within any one country,
which may have pathogenetic implications, has not been examined, probably because not
many countries are known to have a high prevalence of both conditions. China is a vast
country where duodenal ulcer, gastric ulcer and gastric cancer are known to be prevalent
and where a systematic study ofthe distribution ofpeptic ulcer and gastric cancer has not
been reported in the English literature. Such information, together with the knowledge of
the H. pylori prevalence should throw light on the pathogenesis ofthese H. pylori related
conditions. This forms the basis of this review.
GASTRIC CANCER
The overall gastric cancer rate has been declining worldwide in recent decades [22].
However, there has been very little change in China over the last two decades [22].
Gastric cancermortality rates vary tremendously in different parts ofChina, with an over-
all significantly higher prevalence in northern China compared to that in the south
(approximately 3:1). This was borne out by the extensive survey among the communities
of 65 rural counties of China performed by Chen et al. in 1976 (Table 2) [23]. A differ-
ence in gastric cancer rate between the two sexes, with male predominance, was also
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Table 1. H.pylon and Risk of Gastric Cancer.
Duration Cancer Control OR (95 % CI)*
Hawaii Japanese (5) 13 yr 94 percent 76 percent 6.0 (2.1-17.3)
Finland (9) - 70 percent 52 percent 2.2 (1.0-4.4)
United States (4) 14 yr 84 percent 61 percent 3.6 (1.8-7.3)
United Kingdom (3) 6 yr 69 percent 47 percent 2.8 (1.0-8.0)
Sweden (8) - 80 percent 61 percent 2.6 (1.4-5.0)
Taiwan (10) 3 yr 69 percent 59 percent 1.6
Greek (11) - 72 percent 68 percent 1.2
* OR = Odds ratio; CI = confidence interval.
obvious in this epidemiological study. The correlation between the gastric cancer mortal-
ity rate and the H. pylori infection rate in these 65 rural counties ofChina has been doc-
umented by Forman et al. to be significant (p = .02) [1]. Our analysis ofthe available data
in this survey confirms our belief that the populations in northern China have a signifi-
cantly higher gastric cancer rate than those who live in the southern China (Table 2).
Chronic H. pylori infection is known to induce chronic atrophic gastritis, intestinal
metaplasia and dysplasia changes [24]. These are known to be pre-cancerous lesions.
Among the children living in the high gastric cancer risk areas ofChina, ithas been shown
that they have a higher prevalence of H. pylori infection rate as well as a higher gastric
atrophy rate than those who live in the low gastric cancer risk areas. For example, the
overall H. pylori carrier rate in those under 12 years of age was around 20 percent and
around 50 percent in southern and northern China, respectively [25-27]. Similar contrasts
have been reported in other parts ofthe world [28].
DUODENAL AND GASTRIC ULCER
It has long been the impression among gastroenterologists in China that the preva-
lence of duodenal ulcer disease prevalence is much higher in southern China than in the
north. A recent survey among the gastroenterologists practicing in eight major medical
centers in China revealed that the prevalence ofduodenal ulcer in people who had under-
gone the gastroscopy procedure varied significantly between the north (north of the
Yangtze River) and the south of China. The overall prevalence of duodenal ulcer disease
Table 2. Gastric cancer mortality rates (cases per 100,000 population) and H. pylon infection
rates (percent seropositivity) in 65 rural counties of China.
Gastric cancer mortality H. pylori seropositivity
North 25.04 (range: 5.27 - 69.35) 64.9 (range: 27.5 - 93.8)
South 7.7 (range: 1.17 - 82.83) 56.8 (range: 28.9 - 96.2)
p value <.001 .464
Adapted from Chen et al. [23].
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among every 1000 symptomatic individuals in the north and the south was 132 and 232
cases, respectively [29]. There was a statistically significant difference in the duodenal
ulcer rate among the dyspeptics between southern Chinaand northern China. Thus, it con-
firms the long-held beliefthat thepopulations in the south ofChina are moreprone to have
duodenal ulcer disease compared to those in the north, assuming that asymptomatic duo-
denal ulcer disease in both regions isroughly the same. TheH. pyloripositive rate in these
patients, however, is not known in this study apart from that in Hong Kong where duode-
nal ulcer patients have been repeatedly demonstrated to be H. pylori positive in excess of
90 percent [30, 31]. Reports from other centers in southern China revealed that the preva-
lence of H. pylori in duodenal ulcer patients is around 75 percent (52.5 percent-95 per-
cent) [32-37]. In northern China, the H. pylori positivity rate varied from 71.8 percent to
100 percent with an overall rate of 83.9 percent [38-41]. Thus, there is little difference
between the north and the south ofChina withregards to the overall H. pylori rate in these
patients.
Gastric ulcer is consistently less common than duodenal ulcer in 4/6 medical centers
in northern China according to our recent survey. The ratio of duodenal ulcer to gastric
ulcer (DU:GU) varied between 1.44 to 2.19 in these four medical centers. The other two
centers revealed a DU:GU ratio of0.96 and 0.62, respectively. The mean DU:GU ratio in
southern China was 2.77:1 (2.41:1 to 3.12:1). The overall peptic ulcer rate was also high-
erin southern than in northern China. Theprevalence ofH. pyloriinfection in gastric ulcer
patients was 76.4 percent (62 percent-85.8 percent) [32-37] and 73.3 percent (60.6 per-
cent-86 percent) [39, 40] in the south and north ofChina, respectively.
H. pylori positivity rate is significantly higher in patients with duodenal ulcer disease
or gastric ulcer disease than those with non-ulcer dyspepsia or normal asymptomatic sub-
jects [37-39]. According to the limited reports, the H. pylori positive rate was around 45
percent in the non-ulcer dyspepsia subjects. There was a wide variation in the H. pylori
carrier rate in the asymptomatic healthy subjects, both in the north and the south ofChina.
Table 2 shows the results of the sero-epidemiology ofH. pylori positivity rate in a recent
survey performed in 65 rural counties of China scattered both in the north and the south
[23]. There was no significantdifference in the H. pyloricarrier rate between the two parts
ofChina.
H. PYLORI, DUODENAL ULCERAND GASTRIC CANCER
While gastric cancer is more prevalent in northern China and duodenal ulcer more
prevalent in the south, an inverse relationship was actually observed between the duode-
nal ulcer and gastric cancer rates in eight cities of China surveyed, as if suggesting that
duodenal ulceration protected against gastric cancer and vice versa [29]. This inverse
relationship indicates the presence of factors other than H. pylori infection that led to
higher cancer rates in the north and higher duodenal ulcer rates in the south. A recent
endoscopic biopsy survey of the villagers in Changle [42], a county in the Fujian
province of China having one of the highest gastric cancer rates in the country with an
overall incidence of 75 per 100,000 population, showed interesting gastroduodenal
pathologies. H. pylori infection was prevalent in 82 percent of the population.
Duodenitis, active gastritis and atrophic gastritis occurred commonly and at similar rates
in patients with duodenal ulcer, gastric ulcer or gastric cancer. Gastric metaplasia in the
duodenum, however, was more common in patients with duodenal ulcer, whereas intesti-
nal metaplasia in the stomach was more common in patients with gastric dysplasia and
gastric cancer. These findings suggest the presence ofpathogenetic factors other than H.
pylori that led to gastric metaplasia in duodenal ulcer patients on the one hand and to
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intestinal metaplasia in dysplasia and cancer patients on the other. They conform to the
concept ofheterogeneity for peptic ulcer [43] and with the hypothesis that gastric cancer
is the end stage of evolutionary changes including atrophic gastritis, intestinal metapla-
sia and dysplasia with intervening carcinogenic processes such as high salt and dietary
deficiency in antioxidants [24, 28]. The nature of these factors thus remains speculative
and awaits urgent identification.
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